BIOMAT Database Logo BIOMAT Database Logo

Serotonin- and Dopamine-Related Gene Expression in db/db Mice Islets and in MIN6 β-Cells Treated with Palmitate and Oleate. 2016

L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
Departamento de Nutrición, Diabetes y Metabolismo, Escuela de Medicina, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile; Facultad de Medicina, Universidad de los Andes, 7620001 Santiago, Chile.

High circulating nonesterified fatty acids (NEFAs) concentration, often reported in diabetes, leads to impaired glucose-stimulated insulin secretion (GSIS) through not yet well-defined mechanisms. Serotonin and dopamine might contribute to NEFA-dependent β-cell dysfunction, since extracellular signal of these monoamines decreases GSIS. Moreover, palmitate-treated β-cells may enhance the expression of the serotonin receptor Htr2c, affecting insulin secretion. Additionally, the expression of monoamine-oxidase type B (Maob) seems to be lower in islets from humans and mice with diabetes compared to nondiabetic islets, which may lead to increased monoamine concentrations. We assessed the expression of serotonin- and dopamine-related genes in islets from db/db and wild-type (WT) mice. In addition, the effect of palmitate and oleate on the expression of such genes, 5HT content, and GSIS in MIN6 β-cell was determined. Lower Maob expression was found in islets from db/db versus WT mice and in MIN6 β-cells in response to palmitate and oleate treatment compared to vehicle. Reduced 5HT content and impaired GSIS in response to palmitate (-25%; p < 0.0001) and oleate (-43%; p < 0.0001) were detected in MIN6 β-cells. In conclusion, known defects of GSIS in islets from db/db mice and MIN6 β-cells treated with NEFAs are accompanied by reduced Maob expression and reduced 5HT content.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D002394 Catechol O-Methyltransferase Enzyme that catalyzes the movement of a methyl group from S-adenosylmethionone to a catechol or a catecholamine. Catechol Methyltransferase,Catechol-O-Methyltransferase,Catechol O Methyltransferase,Methyltransferase, Catechol,O-Methyltransferase, Catechol
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004296 Dopa Decarboxylase One of the AROMATIC-L-AMINO-ACID DECARBOXYLASES, this enzyme is responsible for the conversion of DOPA to DOPAMINE. It is of clinical importance in the treatment of Parkinson's disease. Decarboxylase, Dopa
D004299 Dopamine beta-Hydroxylase Dopamine beta-Monooxygenase,Dopamine beta Hydroxylase,Dopamine beta Monooxygenase,beta-Hydroxylase, Dopamine,beta-Monooxygenase, Dopamine
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000121 Acetylserotonin O-Methyltransferase An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to N-acetylserotonin to form N-acetyl-5-methoxytryptamine (MELATONIN). Hydroxyindole O-Methyltransferase,Acetylserotonin Methyltransferase,HIOMT,Oxyindol-O-Methyltransferase,Acetylserotonin O Methyltransferase,Hydroxyindole O Methyltransferase,Methyltransferase, Acetylserotonin,O-Methyltransferase, Acetylserotonin,O-Methyltransferase, Hydroxyindole,Oxyindol O Methyltransferase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA2β/Cardiolipin/Opa1 pathway in db/db mice and in Palmitate-treated MIN6 β-cells.
January 2019, International journal of biological sciences,
L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
Sangguayin preparation prevents palmitate-induced apoptosis by suppressing endoplasmic reticulum stress and autophagy in db/db mice and MIN6 pancreatic β-cells.
June 2020, Chinese journal of natural medicines,
L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
Global gene expression analysis in liver of db/db mice treated with catalpol.
August 2018, Chinese journal of natural medicines,
L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
Antioxidant N-acetylcysteine protects pancreatic β-cells against aldosterone-induced oxidative stress and apoptosis in female db/db mice and insulin-producing MIN6 cells.
November 2013, Endocrinology,
L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin.
July 2006, Diabetologia,
L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
Overcoming Insulin Insufficiency by Forced Follistatin Expression in β-cells of db/db Mice.
May 2015, Molecular therapy : the journal of the American Society of Gene Therapy,
L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
Distinct gene expression profiles characterize cellular responses to palmitate and oleate.
August 2010, Journal of lipid research,
L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
A lipidomic screen of palmitate-treated MIN6 β-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking.
April 2011, The Biochemical journal,
L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
Inhibition of GPR40 protects MIN6 β cells from palmitate-induced ER stress and apoptosis.
April 2012, Journal of cellular biochemistry,
L R Cataldo, and M L Mizgier, and D Busso, and P Olmos, and J E Galgani, and R Valenzuela, and D Mezzano, and E Aranda, and V A Cortés, and J L Santos
Fatty acid-induced oxidation and triglyceride formation is higher in insulin-producing MIN6 cells exposed to oleate compared to palmitate.
October 2010, Journal of cellular biochemistry,
Copied contents to your clipboard!